Top Markets
Coin of the day
BIOLASE, Inc. BIOLASE, Inc.

BIOLASE, Inc.

BIOL
Classifica tra le azioni #42643
BIOLASE, Inc., along with its various divisions, operates as a global... BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.
Prezzo delle azioni
$0.00695
Ultima sincronizzazione: 2024-10-29
Capitalizzazione di mercato
$536.40
Variazione (1 giorno)
-0.71%
Variazione (1 anno)
0.00%
Paese
US
Scambia BIOLASE, Inc. (BIOL)

Categoria

Ricavi di BIOLASE, Inc. (BIOL)
Ricavi nel Sep 2024 TTM: $46.03M
Secondo gli ultimi rapporti finanziari di BIOLASE, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $46.03M. Nel 2022, l'azienda ha registrato ricavi di $48.46M un aumento rispetto a i ricavi dell'anno 2021, che erano pari a $39.19M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per BIOLASE, Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $46.03M -6.38%
2023 $49.16M 1.45%
2022 $48.46M 23.67%
2021 $39.19M 72.03%
2020 $22.78M -39.73%
2019 $37.80M -18.10%
2018 $46.16M -1.64%
2017 $46.93M -9.43%
2016 $51.81M 6.88%
2015 $48.48M 1.72%
2014 $47.66M -15.55%
2013 $56.43M -1.61%
2012 $57.36M 17.39%
2011 $48.86M 86.30%
2010 $26.23M -39.50%
2009 $43.35M -32.93%
2008 $64.63M -3.38%
2007 $66.89M -4.03%
2006 $69.70M 12.46%
2005 $61.98M 2.19%
2004 $60.65M 23.57%
2003 $49.08M 68.09%
2002 $29.20M 63.24%
2001 $17.89M 85.22%
2000 $9.66M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$46.59B 101,114.53%
US
$25.84B 56,035.66%
US
$35.48B 76,995.55%
IE
$21.00B 45,517.69%
US
$6.51B 14,049.18%
US